Perrigo Company

Perrigo Company has restructured in an effort to enhance the management of the company’s global operations. John Hendrickson has been named executive vice president of global operations and supply chain. Mr. Hendrickson will be responsible for the global manufacturing and supply chain functions for all of Perrigo’s finished dosage consumer healthcare and Rx products. He will oversee operations in the U.S., UK, and Mexico as well as Perrigo New York and Perrigo Israel. Most recently, he managed the company’s consumer healthcare business.

Joe Papa, Perrigo’s president and chief executive officer, stated, “John brings more than 20 years of industry experience to his new position. He will establish our manufacturing strategic direction, determine capital allocation and maximize the effectiveness of our entire supply chain. I believe the company is extremely fortunate to have a leader of John’s caliber to spearhead this integration effort.”

Also, Sharon Kochan has been promoted to executive vice president of U.S. Generics. Mr. Kochan will be responsible for expanding the generic business in the U.S. market and coordinating the business development activities of our global generic business. He has served in a number of strategic leadership roles since joining Perrigo Israel in 1994, including three years in operational management positions at Perrigo New York. Most recently, he served as senior vice president of global generic/API strategy and business development.

Mr. Kochan is replacing Adam Levitt who is leaving the company to pursue other interests. Mr. Papa commented, “Following the acquisition of Perrigo Israel in 2005, Adam led the development of our generic drug sales in the U.S., provided guidance to our global R&D functions, and, as a member of the executive committee, helped coordinate the integration of our two major businesses. I appreciate his contribution during the past two years and wish him the best in his future endeavors.”